Close
Nordic 9Nordic 9

Northpond Ventures (investor - Venture Capital)

United States northpondventures.com
See something wrong or missing? Let us know
Offices:Bethesda
Average round investment:51.84M USD
Average number per year:1.8
Distribution: 2026 (1)2022 (4)2021 (1)2020 (1)
Portfolio companies: United Kingdom Mestag TherapeuticsSwitzerland Opna BioGermany Molecule See the entire list
Mostly invests in: United Kingdom United Kingdom (5) Health services (6)
See the entire list

Showing 3 of 7 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Northpond Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Northpond Ventures

Name Criteria
United Kingdom Alan Howard
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
South Korea Korea Investment Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States New Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Netherlands Partners in Equity
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Marketplace
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Famille C Venture
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Marketplace
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom abrdn
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Japan Presidio Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Pharma, Marketplace
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Korify Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany Haniel
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Lauxera Capital Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top